HIV

Health Helen Branswell

Patient Zero in AIDS crisis was misidentified, study says, rewriting early history of virus

In the Lab Sharon Begley

CRISPR identifies genes that might be targeted to hobble HIV infection

Pharmalot Ed Silverman

Gilead asks FDA to expand exclusivity for a key HIV drug

In the Lab Shayla Love

Genetic fossil-hunters dig through HIV’s long history for clues to new treatments

In the Lab Andrew Joseph

A drug used to treat Crohn’s disease could suppress HIV, monkey study suggests

Health Dylan Scott

In Trump’s America, towns in poor health don’t think he will save them

Heavyweights Rebecca Robbins

The drug pricing crusader at the center of one of the nastiest fights of the election season

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: FDA approves a biosimilar version of Enbrel

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Glaxo believes its plan for HIV treatment is a ‘game changer’

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Another analysis finds new cholesterol drugs are not cost-effective

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Gilead’s preventive HIV pill must be covered in England

Health Lindzi Wessel

High rates of injection drug use increases gay teens’ HIV risk

First Opinion Peter Piot and Mitchell Warren

Prevention must be at the forefront to meet global HIV goals

Health Ike Swetlitz

HIV drugs protect against transmission, even in unprotected sex

Pharmalot Ed Silverman

Gilead’s new price hikes on HIV drugs anger AIDS activists

Business Rebecca Robbins

Gilead hikes price of HIV therapies, other drugs by up to 10 percent

In the Lab Eric Boodman

Inside a monkey lab, research gets fast-tracked in the ‘Zika room’